Preclinical development of bicyclic nucleoside analogues as potent and selective inhibitors of varicella zoster virus - Concepedia

Concepedia

Publication | Closed Access

Preclinical development of bicyclic nucleoside analogues as potent and selective inhibitors of varicella zoster virus

73

Citations

14

References

2007

Year

Christopher McGuigan, Ranjith Pathirana, Marco Migliore, Rina Adak, G Luoni, Arwyn T. Jones, Alberto Diez‐Torrubia, Marı́a-José Camarasa, Sonsoles Velázquez, Geoffrey Henson,

Journal of Antimicrobial Chemotherapy

Abstract

On the basis of its favourable antiviral and pharmacokinetic properties, FV-100 is now being pursued as the clinical BCNA candidate for the treatment of VZV shingles.

References

	Year	Citations

Page 1